Signal2026-07-23
ClinicalTrials.gov

[PHASE3] Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery

Part of

Ferroptosis Targeted Lung Cancer Therapies

Open primary sourceRead on Substack